Validation of the Korean Version of the Walking Impairment Questionnaire in Patients With Peripheral Arterial Disease
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The aim of the study is to validate the Korean version of Walking Impairment Questionnaire in patients with peripheral arterial occlusive disease.
| Condition |
|---|
|
Peripheral Arterial Occlusive Disease |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Prospective |
| Official Title: | Validation of the Korean Version of the Walking Impairment Questionnaire in Patients With Peripheral Arterial Disease |
| Estimated Enrollment: | 50 |
| Study Start Date: | August 2012 |
| Estimated Study Completion Date: | August 2014 |
| Estimated Primary Completion Date: | August 2014 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
Medical treatment
only medical treatment (regardless of the kinds of medicine)
|
|
Surgical or endovascular treatemnt group
patients underwent surgery or endovascular therapy
|
Detailed Description:
First, the original version of WIQ will be translated into Korean, then it will be translated into English, again. The translated version will be sent to the original author to compare with the original version. After correcting, the Korean version will be completed.
The patients with peripheral arterial disease will fill in the Korean version of WIQ before starting treatments. Baseline results of arterial function test, toe-brachial index and treadmill test will be recorded. Three months later, the patients will complete the questionnaire again. Arterial function test, toe-brachial index and treadmill test also will be taken again after treatment and the correlation of WIQ and other exams will be evaluated.
Eligibility| Ages Eligible for Study: | 19 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Patients with peripheral arterial disease
Inclusion Criteria:
- 19~ 80 years
- claudication
- Ankle brachial index < 0.9 or TBI < 0.7 (in patients with DM and ABI higher than 1.3)
- patients who can complete the treadmill test (slope 12%, 2.4km/hr)
Exclusion Criteria:
- critical limb ischemia
- Ankle pressure < 40mmHg
- claudication due to other causes (i.e. spinal stenosis, arthritis, etc)
- patients with high risk of coronary artery syndrome during treadmill test
Contacts and Locations| Contact: Seung-Kee Min, M.D.,PhD | 82-2-2072-0297 | docmin88@snu.ac.kr |
| Korea, Republic of | |
| Seoul National University Hospital | Not yet recruiting |
| Seoul, Korea, Republic of, 110-744 | |
| Contact: Seung-Kee Min, M.D.,PhD 82-2-2072-0297 docmin88@snu.ac.kr | |
More Information
No publications provided
| Responsible Party: | Seung-Kee Min, Professor, Seoul National University Hospital |
| ClinicalTrials.gov Identifier: | NCT01654471 History of Changes |
| Other Study ID Numbers: | WIQ-SNU |
| Study First Received: | July 27, 2012 |
| Last Updated: | July 30, 2012 |
| Health Authority: | Korea: Institutional Review Board |
Keywords provided by Seoul National University Hospital:
|
Walking Impairment Questionnaire Peripheral arterial occlusive disease Korean version |
Additional relevant MeSH terms:
|
Arterial Occlusive Diseases Peripheral Arterial Disease Peripheral Vascular Diseases Vascular Diseases |
Cardiovascular Diseases Atherosclerosis Arteriosclerosis |
ClinicalTrials.gov processed this record on May 23, 2013